Perspectives
Arise, Sir Billy Connolly
Billy Connolly receives a knighthood
READ MORE
Prep:
Cook:
Serves:
More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.
The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.
Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.
Billy Connolly receives a knighthood
READ MORE
Video: Parkinson’s communities share experiences of the condition
READ MORE
David Plummer shares more of his top photographs of wildlife in action
READ MORE
Comments